Jyoti CNC Automation (JYOTICNC) Q3 24/25 earnings summary

Executive summary

• Achieved sixth consecutive quarter of robust growth, with Q3 FY25 consolidated revenue rising 19% year-over-year to ₹4,495 million and EBITDA increasing 39% to ₹1,126 million, maintaining a 25% margin.

• Net profit for Q3 FY25 surged 67% year-over-year to ₹802 million; PAT for nine months FY25 rose 304% to ₹2,070 million.

• Order book as of December 31, 2024, stands at ₹43,597 million, with significant contributions from aerospace and auto sectors.

• Board approved unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2024, reviewed by the audit committee and statutory auditors.

• Completed IPO in FY24, raising ₹9,999.99 million, with proceeds fully utilized for debt repayment, working capital, and corporate purposes.

Financial highlights

• Nine months FY25 consolidated revenue grew 40% year-over-year to ₹12,420 million; EBITDA up 88% to ₹3,130 million, with margin at 25.2%.

• Q3 FY25 net profit: ₹802 million, up 67% year-over-year; nine months net profit: ₹2,070 million, up 304%.

• Q3 FY25 order inflow was ₹492 crore; order book split: 41% aerospace, 16% auto, 18% general engineering.

• Huron subsidiary contributed ₹200 crore revenue in nine months, ₹65 crore in Q3, with EBITDA margin at 15.75%.

• Finance costs decreased 54% in Q3 FY25 and 55% in 9M FY25 year-over-year.

Outlook and guidance

• Capacity bottlenecks addressed in Q3; additional facilities expected to drive higher growth in Q4 and beyond.

• Order book executable over 2.5 years at current run rate, with capacity expansion aiming to accelerate delivery.

• Ongoing expansion of manufacturing capacity, with an additional 10,000 machines per annum to be added in the next two fiscal years.

• Focused on growth in aerospace, EMS, electric vehicles, and semiconductor sectors, all expected to see significant market expansion.

• Management expects recovery in the business of the operating step-down subsidiary and considers no impairment necessary for investments.